Development and Validation of a Machine-Learning ALS Survival Model Lacking Vital Capacity (VC-Free) for use in Clinical Trials during the COVID-19 Pandemic

Danielle Beaulieu, James D. Berry, Sabrina Paganoni, Jonathan D. Glass, Christina Fournier, Jonavelle Cuerdo, Mark Schactman, David L. Ennist.

DOI: 10.1080/21678421.2021.1924207

Published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, on August 4, 2021.  This article is accessible on-line by clicking here.

Our paper is part of a special supplement of ALS-FTD edited by Dr. Angela Genge devoted to pulmonary function assessment in ALS, an issue of widespread concern during the Covid pandemic. The special supplement is available here.